EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $379,000 | +31.6% | 6,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $288,000 | +2.1% | 6,900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $282,000 | -11.6% | 6,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $319,000 | +11.5% | 6,900 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $286,000 | -26.5% | 6,900 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $389,000 | -48.7% | 6,900 | -50.0% | 0.00% | -50.0% |
| Q2 2019 | $759,000 | +30.6% | 13,800 | +62.4% | 0.00% | +33.3% |
| Q1 2019 | $581,000 | +116.8% | 8,500 | +23.2% | 0.00% | +50.0% |
| Q4 2018 | $268,000 | -53.9% | 6,900 | -18.8% | 0.00% | -33.3% |
| Q3 2018 | $581,000 | -12.1% | 8,500 | -2.3% | 0.00% | -25.0% |
| Q2 2018 | $661,000 | +45.6% | 8,700 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $454,000 | -8.5% | 8,700 | -2.2% | 0.00% | -25.0% |
| Q4 2017 | $496,000 | 0.0% | 8,900 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $496,000 | -29.3% | 8,900 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $702,000 | -4.9% | 8,900 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $738,000 | -2.4% | 8,900 | -7.8% | 0.01% | -12.5% |
| Q4 2016 | $756,000 | +21.3% | 9,650 | +8.4% | 0.01% | +14.3% |
| Q3 2016 | $623,000 | +80.1% | 8,900 | 0.0% | 0.01% | +75.0% |
| Q2 2016 | $346,000 | -4.7% | 8,900 | -4.3% | 0.00% | 0.0% |
| Q1 2016 | $363,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |